153 related articles for article (PubMed ID: 9450610)
1. Long-lasting salivation induced by a novel muscarinic receptor agonist SNI-2011 in rats and dogs.
Masunaga H; Ogawa H; Uematsu Y; Tomizuka T; Yasuda H; Takeshita Y
Eur J Pharmacol; 1997 Nov; 339(1):1-9. PubMed ID: 9450610
[TBL] [Abstract][Full Text] [Related]
2. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N
Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361
[TBL] [Abstract][Full Text] [Related]
3. Sialogogic activities of SNI-2011 compared with those of pilocarpine and McN-A-343 in rat salivary glands: identification of a potential therapeutic agent for treatment of Sjörgen's syndrome.
Iwabuchi Y; Masuhara T
Gen Pharmacol; 1994 Jan; 25(1):123-9. PubMed ID: 7517901
[TBL] [Abstract][Full Text] [Related]
4. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 1st communication: effects on general behavior and central nervous system.
Arisawa H; Imai E; Fujise N; Fukui K; Masunaga H
Arzneimittelforschung; 2002; 52(1):14-20. PubMed ID: 11838269
[TBL] [Abstract][Full Text] [Related]
5. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 4th communication: Effects on gastrointestinal, urinary and reproductive systems and other effects.
Arisawa H; Fukui K; Imai E; Fujise N; Masunaga H
Arzneimittelforschung; 2002; 52(4):225-32. PubMed ID: 12040964
[TBL] [Abstract][Full Text] [Related]
6. (+/-)-cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride) induces saliva and tear secretions in rats and mice: the role of muscarinic acetylcholine receptors.
Iga Y; Arisawa H; Ogane N; Saito Y; Tomizuka T; Nakagawa-Yagi Y; Masunaga H; Yasuda H; Miyata N
Jpn J Pharmacol; 1998 Nov; 78(3):373-80. PubMed ID: 9869272
[TBL] [Abstract][Full Text] [Related]
7. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 2nd communication: effects on somatic nervous system and on autonomic nervous system and smooth muscle.
Arisawa H; Fukui K; Fujise N; Masunaga H
Arzneimittelforschung; 2002; 52(2):81-8. PubMed ID: 11878203
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and metabolism of the novel muscarinic receptor agonist SNI-2011 in rats and dogs.
Washio T; Kohsaka K; Arisawa H; Masunaga H
Arzneimittelforschung; 2003; 53(1):26-33. PubMed ID: 12608011
[TBL] [Abstract][Full Text] [Related]
9. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 3rd communication: effects on respiratory and cardiovascular systems.
Arisawa H; Fukui K; Masunaga H
Arzneimittelforschung; 2002; 52(3):162-7. PubMed ID: 11963642
[TBL] [Abstract][Full Text] [Related]
10. Effect of SNI-2011 on amylase secretion from parotid tissue in rats and in neuronal nitric oxide synthase knockout mice.
Yuan Z; Iida H; Inoue N; Ishikawa Y; Ishida H
Eur J Pharmacol; 2003 Mar; 464(2-3):197-206. PubMed ID: 12620514
[TBL] [Abstract][Full Text] [Related]
11. Distinct effects of cevimeline and pilocarpine on salivary mechanisms, cardiovascular response and thirst sensation in rats.
Ono K; Inagaki T; Iida T; Wakasugi-Sato N; Hosokawa R; Inenaga K
Arch Oral Biol; 2012 Apr; 57(4):421-8. PubMed ID: 22099058
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of cevimeline vs. pilocarpine in the secretion of saliva: a pilot study.
Brimhall J; Jhaveri MA; Yepes JF
Spec Care Dentist; 2013; 33(3):123-7. PubMed ID: 23600983
[TBL] [Abstract][Full Text] [Related]
13. Moxonidine reduces pilocarpine-induced salivation in rats.
Moreira TS; Thomaz AC; De Luca LA; Renzi A; Menani JV
Auton Neurosci; 2001 Aug; 91(1-2):32-6. PubMed ID: 11515799
[TBL] [Abstract][Full Text] [Related]
14. Persistent increase in the amount of aquaporin-5 in the apical plasma membrane of rat parotid acinar cells induced by a muscarinic agonist SNI-2011.
Ishikawa Y; Skowronski MT; Ishida H
FEBS Lett; 2000 Jul; 477(3):253-7. PubMed ID: 10908730
[TBL] [Abstract][Full Text] [Related]
15. Role of the medial septal area on pilocarpine-induced salivary secretion and water intake.
Paulin RF; Menani JV; Colombari E; De Paula PM; Colombari DS
Brain Res; 2009 Nov; 1298():145-52. PubMed ID: 19728997
[TBL] [Abstract][Full Text] [Related]
16. Pilocarpine-induced salivation and thirst in conscious rats.
Sato N; Ono K; Honda E; Haga K; Yokota M; Inenaga K
J Dent Res; 2006 Jan; 85(1):64-8. PubMed ID: 16373683
[TBL] [Abstract][Full Text] [Related]
17. Lesions of the lateral hypothalamus impair pilocarpine-induced salivation in rats.
Renzi A; De Luca LA; Menani JV
Brain Res Bull; 2002 Sep; 58(5):455-9. PubMed ID: 12242097
[TBL] [Abstract][Full Text] [Related]
18. A pharmacokinetic and pharmacodynamic study of intravenous pilocarpine in humans.
Tanzer JM; Kramer PA; Schulman P; Willard AK
J Dent Res; 1995 Dec; 74(12):1845-9. PubMed ID: 8600180
[TBL] [Abstract][Full Text] [Related]
19. Effects of cevimeline on salivation and thirst in conscious rats.
Sato N; Ono K; Haga K; Yokota M; Inenaga K
Arch Oral Biol; 2007 Jan; 52(1):26-9. PubMed ID: 17049480
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of pilocarpine and cevimeline on salivary flow.
Braga MA; Tarzia O; Bergamaschi CC; Santos FA; Andrade ED; Groppo FC
Int J Dent Hyg; 2009 May; 7(2):126-30. PubMed ID: 19416095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
